CY2324B1 - (4-Piperidinyl)-1H-2-benzopyran derivatives usefulas antipsychotic agents. - Google Patents

(4-Piperidinyl)-1H-2-benzopyran derivatives usefulas antipsychotic agents.

Info

Publication number
CY2324B1
CY2324B1 CY0300037A CY0300037A CY2324B1 CY 2324 B1 CY2324 B1 CY 2324B1 CY 0300037 A CY0300037 A CY 0300037A CY 0300037 A CY0300037 A CY 0300037A CY 2324 B1 CY2324 B1 CY 2324B1
Authority
CY
Cyprus
Prior art keywords
usefulas
piperidinyl
antipsychotic agents
benzopyran derivatives
benzopyran
Prior art date
Application number
CY0300037A
Other languages
English (en)
Inventor
Joseph T Strupczewski
Kenneth J Bordeau
Shelley L Pavlek
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of CY2324B1 publication Critical patent/CY2324B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CY0300037A 1997-02-07 2003-04-30 (4-Piperidinyl)-1H-2-benzopyran derivatives usefulas antipsychotic agents. CY2324B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79710797A 1997-02-07 1997-02-07

Publications (1)

Publication Number Publication Date
CY2324B1 true CY2324B1 (en) 2003-11-14

Family

ID=25169927

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0300037A CY2324B1 (en) 1997-02-07 2003-04-30 (4-Piperidinyl)-1H-2-benzopyran derivatives usefulas antipsychotic agents.

Country Status (22)

Country Link
EP (1) EP1015446B1 (no)
JP (1) JP4177461B2 (no)
KR (1) KR100509878B1 (no)
CN (1) CN1092653C (no)
AR (1) AR011614A1 (no)
AT (1) ATE236150T1 (no)
AU (1) AU725301B2 (no)
BR (1) BRPI9807312B8 (no)
CA (1) CA2281702C (no)
CY (1) CY2324B1 (no)
DE (1) DE69812980T2 (no)
DK (1) DK1015446T3 (no)
ES (1) ES2194303T3 (no)
HK (1) HK1027812A1 (no)
HU (1) HUP0001308A3 (no)
IL (1) IL131243A (no)
NO (1) NO318936B1 (no)
NZ (1) NZ336719A (no)
PT (1) PT1015446E (no)
TW (1) TW518333B (no)
WO (1) WO1998034933A1 (no)
ZA (1) ZA98831B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1749001T3 (da) * 2004-04-29 2010-06-28 Aventis Pharma Inc 3-piperidinylisochroman-5-ol som dopaminagonister
PL1748767T3 (pl) 2004-05-28 2012-08-31 Unigen Inc 1-(3-metylo-2,4-dimetoksyfenylo)-3-(2',4'-dihydroksyfenylo)-propan jako silny inhibitor tyrozynazy
EP2183245B1 (en) 2007-07-26 2014-07-09 F. Hoffmann-La Roche AG Dual modulators of 5-ht2a and d3 receptors
JP2011528719A (ja) 2008-07-21 2011-11-24 ユニジェン・インコーポレーテッド スキンホワイトニング(色を薄くする)化合物系列
US8877778B2 (en) 2010-12-15 2014-11-04 Hoffmann-La Roche Inc. Benzofurane compounds
CN102079720B (zh) * 2011-01-20 2013-02-06 蚌埠丰原医药科技发展有限公司 一种制备1-苄基-4-哌啶甲醛的方法
CN109180448A (zh) 2011-03-24 2019-01-11 尤尼根公司 用于制备二芳基丙烷的化合物和方法
US8921397B2 (en) 2011-05-04 2014-12-30 Hoffmann-La Roche Inc. Benzofurane-piperidine compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
US4963568A (en) * 1989-05-31 1990-10-16 Abbott Laboratories Dopamine agonists

Also Published As

Publication number Publication date
BRPI9807312B8 (pt) 2016-09-13
PT1015446E (pt) 2003-08-29
HUP0001308A3 (en) 2001-07-30
WO1998034933A1 (en) 1998-08-13
CN1246859A (zh) 2000-03-08
JP4177461B2 (ja) 2008-11-05
EP1015446B1 (en) 2003-04-02
DE69812980T2 (de) 2003-11-13
ZA98831B (en) 1998-08-07
AR011614A1 (es) 2000-08-30
AU725301B2 (en) 2000-10-12
ATE236150T1 (de) 2003-04-15
KR100509878B1 (ko) 2005-08-25
TW518333B (en) 2003-01-21
CN1092653C (zh) 2002-10-16
KR20000070862A (ko) 2000-11-25
EP1015446A1 (en) 2000-07-05
HUP0001308A2 (hu) 2001-06-28
NO318936B1 (no) 2005-05-30
BR9807312A (pt) 2000-05-02
CA2281702A1 (en) 1998-08-13
JP2001512436A (ja) 2001-08-21
BR9807312B1 (pt) 2013-10-29
DE69812980D1 (de) 2003-05-08
IL131243A (en) 2004-02-19
ES2194303T3 (es) 2003-11-16
NO993812D0 (no) 1999-08-06
DK1015446T3 (da) 2003-07-14
AU5923798A (en) 1998-08-26
NO993812L (no) 1999-10-05
NZ336719A (en) 2000-10-27
HK1027812A1 (en) 2001-01-23
IL131243A0 (en) 2001-01-28
CA2281702C (en) 2006-04-11

Similar Documents

Publication Publication Date Title
EG24743A (en) Heterocyclic compounds.
IL147108A0 (en) Substituted heterocycle fused gamma-carbolines
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
GB9715892D0 (en) Heterocyclic compounds
ZA9811345B (en) Piperidine derivatives
HK1046400A1 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives
ZA992191B (en) Piperidine derivatives.
ZA200101830B (en) Piperidine derivatives.
CY2324B1 (en) (4-Piperidinyl)-1H-2-benzopyran derivatives usefulas antipsychotic agents.
ZA982436B (en) Thiazolimine derivatives.
IL123860A0 (en) Phenoxymethyl piperidine derivatives
ZA988206B (en) Piperidinylmethyloxazolidinone derivative.
ZA986189B (en) Substituted 2-(benzaryl)pyridines.
SI1015446T1 (en) (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents
ZA981307B (en) 4-aminoethoxyindazole derivatives.
IL135195A0 (en) Substituted piperidine derivatives
GB9918623D0 (en) Lathe
EP1011665A4 (en) HETEROCYCLIC AGENTS
ZA991549B (en) 2-Arylethyl-(piperidin-4-ylmethyl)amine derivatives.
ZA982618B (en) Phenoxymethyl piperidines derivatives
ZA984948B (en) Benzimidazole derivatives.
ZA981224B (en) Benzimidazole derivatives.
GB9715893D0 (en) Heterocyclic derivatives
GB9715970D0 (en) Heterocyclic derivatives
GB9715735D0 (en) Heterocyclic compounds